Durable remission of a relapsing primary central nervous system lymphoma after autologous bone marrow transplantation

Bone Marrow Transplant. 1996 Nov;18(5):1021-3.

Abstract

A 30-year-old patient with a relapsing primary central nervous system lymphoma (PCNSL), was successfully treated with salvage chemotherapy and high-dose therapy including drugs that cross the blood-brain barrier followed by ABMT. Cerebrospinal irradiation was administered after hematological recovery. Six years after transplantation the patient is alive without evidence of recurrent disease with a good neuropsychological status. This result could justify further studies of aggressive management of PCNSL in relapse.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Bone Marrow Transplantation*
  • Brain Neoplasms / pathology
  • Brain Neoplasms / therapy*
  • Female
  • Humans
  • Lymphoma / pathology
  • Lymphoma / therapy*
  • Recurrence
  • Transplantation, Autologous